BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Jun 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-06-04

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-04	Common Stock	F	2036	$120.46	Disposed	74710	Direct
2015-06-05	Common Stock	S	1864	$122.3181	Disposed	72846	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on March 2, 2015.

F2: The price in column 4 is a weighted average price. The price actually received ranged from $119.94 to $123.83. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.